Primary resistance to BCMA-targeted bispecifics in multiple myeloma, emapalumab therapy in hemophagocytic lymphohistiocytosis, and chemotherapy-induced pyroptosis as a mechanism of thrombus formation in patients with cancer
This episode of Blood Podcast discusses primary resistance to BCMA-targeted bispecifics in multiple myeloma, the effects of emapalumab therapy on hemophagocytic lymphohistiocytosis outcomes, and the role of pyroptosis in chemotherapy-induced thrombosis in cancer patients.